ACTN-3 and ACE genotypes in elite male Italian athletes

Myosotis Massidda 1 , Laura Corrias 1 , Marco Scorcu 2 , Giuseppe Vona 1 , and Maria Carla Calò 1
  • 1 Department of Environmental and life Science, University of Cagliari, Italy
  • 2 FMSI CR Sardegna and Cagliari Calcio SpA, Italy


The ACE I/D and the ACTN-3 R577X polymorphisms are the most studied genes associated with elite athlete status, even if this association has been often conflicting. The aim of the present study was to investigate the association between the ACE and the ACTN3 genotypes and elite performance in Italian male athletes. The ACTN-3 R577X and the ACE I/D genotype distributions of 59 elite male Italian athletes practicing gymnastics (G; n = 17), 100 m-400 m running (R; n = 12), and playing soccer (S; n= 30) were compared with controls from Italian (C; n = 31) populations. For ACE distribution, athletes did not differ from controls (G, χ2 = 0.37, df = 2, p = 0.82; R, χ2 = 1.90, df = 2, p = 0.45; S, χ2 = 1.48, df = 2, p = 0.47) and the DD genotype was at very high frequency in all groups (G = 53%, R= 50%, S = 60%, C = 45%). For ACTN-3 distribution, elite gymnasts showed a significant difference from controls (χ2 = 6.57, df = 2, p = 0.03), showing an absence of XX genotype. Soccer players and runners did not differ from controls in ACTN-3 genotype distribution (R, χ2 =0.43, df = 2, p = 0.80; S, χ2 = 1.25, df = 2, p = 0.53). Even if the ACE DD genotype is often positively associated with elite sprint/power athlete status, its high frequency in Italian populations eliminates the possibility of its exclusive association in Italian athletes. The results of ACTN3 genotypes suggest that RR genotype of ACTN-3 gene is a determinant of elite gymnasts status but it is not the key factor for achieving a top-level performance in soccer or track events.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Alvarez R, Terrados N, Ortolano R, Iglesias- Cubero G, Reguero JR, Batalla A, et. al. 2000. Genetic variation in the renin- angiotensin system and athletic performance. Eur J Appl Physiol 82:117-20.

  • Aucella F, Vigilante M, Margaglione M, Grandone E, del Popolo A, Forcella M, et al. 2000. Polymorphism of the Angiotensin- Converting Enzyme gene in End- Stage Renal Failure Patients. Nephron 85:54-59.

  • Berman Y, North KN. 2010. A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism. Physiology (Bethesda) 25:250-5.

  • Bray MS, Hagberg JM, Pe’Russe L, Rankinen T, Roth SM, Wolfarth B, et al. 2009. The Human Gene Map for Performance and Health-Related Fitness Phenotypes: The 2006-2007 Update. Med Sci Sports Exerc 41:34-72.

  • Bouchard C, Lesage R, Lortie G, Simoneau JA, Hamel P, Boulay MR, 1986. Aerobic performance in brothers, dizygotic and monozygotic twins. Med Sci Sports Exerc 18:639-46.

  • Bustamante-Ara N, Santiago C, Verde Z, Yvert T, Gómez-Gallego F, Rodríguez-Romo G, et al. 2010. ACE and ACTN3 genes and muscle phenotypes in nonagenarians. Int J Sports Med 31:221-24 Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, et al. 2005. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 99:154-63.

  • Coates D. 2003. The angiotensin converting enzyme (ACE). Int J Biochem Cell Biol 35:769-73.

  • Collins M, Xenophontos SL, Cariolou MA, Mokone GG, Hudson DE, Anastasiades L, et al. 2004. The ACE gene and endurance performance during the South African36:1314-20.

  • De Proft E, Cabri J, Dufour W, Clarys JP. 1988. Strength training and kick performance in soccer players. In: T Reilly, A Lees, K Davids, WJ Murphy, editors. Science and Football. London: E & FN Spon. 108-13.

  • Druzhevskaya AM, Ahmetov II, Stratenkova IV, Rogozkin VA. 2008. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol 103:631-34.

  • Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, et al. 1998. Elite endurance athletes and the ACE I allele-the role of genes in athletic performance. Hum Genet 103;48-50.

  • Hanson ED, Ludlow AT, Sheaff AK, Park J, Roth SM. 2010. ACTN3 Genotype Does not Influence Muscle Power. Int J Sports Med 31:834-38.

  • Jones A, Montgomery HE, Woods DR. 2002. Human performance: a role for the ACE genotype? Exerc Sport Sci Rev 30:184-90.

  • Jones A, Woods DR. 2003. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 35:855-66.

  • Juffer P, Furrer R, González-Freire M, Santiago C, Verde Z, Serratosa L, et al. 2009. Genotype distributions in top-level soccer players: a role for ACE? Int J Sports Med 30:387- 92.

  • Karjalainen J, Kujala UM, Stolt A, Mantysaari M, Viitasalo M, Kainulainen K, et al. 1999. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 34:494-99.

  • Lucia A, Olivan J, Gomez-Gallego F, Santiago C, Montil M, Foster C. 2007. Citius and longius (faster and longer) with no alpha-actinin-3 in skeletal muscles? Br J Sports Med 41:616-17.

  • Massidda M, Vona, G, Calò CM. 2009. Association Between the ACTN3 R577X Polymorphism and Artistic Gymnastic Performance in Italy. Genet Test Mol Biomarkers 13:377-80.

  • Massidda M, Vona G, Calò CM. 2011. Lack of association between ACE insertion/ deletion polymorphism and elite artistic gymnastic performance in Italians. Eur J Sports Sci 11:149-53.

  • Mills MA, Yang N, Weinberger RP, Woude DLV, Beggs AH, Easteal S, et al. 2001. Differential expression of the actin-binding proteins, alfa-actin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet 10:1335-46.

  • Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, et al. 1998. Human gene for physical performance. Nature 393:221-22.

  • Moran CN, Yang N, Bailey ME, Tsiokanos A, Jamurtas A, MacArthur DG, et al. 2007. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet 15:88-93.

  • Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H. 1999. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 87:1313-16.

  • Nazarov IB, Woods DR, Montgomery HE, Shneider OV, Kazakov VI, Tomilin NV, et al. 2001. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet: 9:797-801.

  • North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH. 1999. A common nonsense mutation results in a-actinin-3 deficiency in the general population. Nature Genetics 21:353-54.

  • Rankinen T, Wolfarth B, Simoneau JA, Maier- Lenz D, Rauramaa R, Rivera MA, et al. 2000. No association between the angiotensin- converting enzyme I/D polymorphism and elite endurance athlete status. J Appl Physiol 88:1571-75.

  • Reilly T, Doran D. 1999. Kinanthropometric and performance profiles of elite Gaelic footballers. J Sports Sci 17:92.2 Ruiz JR, Arteta D, Buxens A, Artieda M, Gomez- Gallego F, Santiago C, et al. 2009Can we identified a power-oriented polygenic profile? J Appl Physiol 108:561-66.

  • Ruiz JR, Fernandez del Valle M, Verde Z, Dıez-Vega I, Santiago C, Yvert T, et al. 2011. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scand J Med Sci Sports 21:e-34-41.

  • Santiago C, Gonzalez-Freire M, Serratosa L, Morate FJ, Meyer T, Gomez-Gallego F, et al. 2008. ACTN3 genotype in professional soccer players. Br J Sports Med 42:71-73.

  • Santiago C, Ruiz JR, Muniesa CA, Gonzalez- Freire M, Gomez-Gallego F, Lucia A. 2009. Does the polygenic profile determine the potential for becoming a worldclass athlete? Insights from the sport of rowing. Scand J Med Sci Sports 20:e188-94.

  • Santiago C, Rodriguez-Romo G, Gomez-Gallego F, Gonzalez-Freire M, Yvert T, Verde Z, et al. 2010. Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults? Scand J Med Sci Sports 20:771-78.

  • Scanavini D, Bernardi F, Castoldi E, Conconi F, Mazzoni G. 2002. Increased frequency of the homozygous II ACE genotype in Italian Olympic endurance athletes. Eur J Hum Genet 10:576-77.

  • Scott RA, Irving R, Irwin L, Morrison E, Charlton V, Austin K, et al. 2010. ACTN3 and ACE genotypes in elite Jamaican and US sprinters. Med Sci Sports Exec, 42, 107-12.

  • Taylor RR, Mamotte CD, Fallon K, van Bockxmeer FM. 1999. Elite athletes and the gene for angiotensin-converting enzyme. J Appl Physiol 87:1035-37.

  • Tsianos G, Sanders J, Dhamrait S, Humphries S, Grant S, Montgomery H. 2004. The ACE gene insertion/deletion polymorphism and elite endurance swimming. Eur J Appl Physiol 92:360-62.

  • Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leemputte M, Hespel P, et al. 2007. ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics 32:58-63.

  • Woods D, Hickman M, Jamshidi Y, Brull D, Vassiliou V, Jones A, et al. 2001. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet 108:230-32.

  • Yang N, MacArthur D, Gulbin JP, Hahn AG, Beggs AH, Easteal S, et al. 2003. ACTN3 Genotype Is Associated with Human Elite Athletic Performance. Am J Hum Genet 73:627-31.


Journal + Issues